MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA

/PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing...

Related Keywords

Canada ,Canadian ,Miri Halperin Wernli ,Exchange Commission ,Company Annual Report On Form ,Prnewswire Mind Medicine Mindmed Inc ,Company Or Mindmed ,Matthias Liechti At University Hospital Basel ,Nasdaq ,Medicine Mindmed Inc ,Matthias Liechti ,University Hospital Basel ,Executive President ,Visual Analog Scales ,Altered States ,Annual Report ,Quarterly Reports ,Note Regarding Forward Looking Statements ,Financial Condition ,Mind Medicine Mindmed Inc ,